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Examining the effect of smoking on suicidal
ideation and attempts: triangulation of
epidemiological approaches
Ruth Harrison, Marcus R. Munafò, George Davey Smith and Robyn E. Wootton
Background
Previous literature has demonstrated a strong association
between cigarette smoking, suicidal ideation and suicide
attempts. This association has not previously been examined in a
causal inference framework and could have important implica-
tions for suicide prevention strategies.
Aims
We aimed to examine the evidence for an association between
smoking behaviours (initiation, smoking status, heaviness, life-
time smoking) and suicidal thoughts or attempts by triangulating
across observational and Mendelian randomisation analyses.
Method
First, in the UK Biobank, we calculated observed associations
between smoking behaviours and suicidal thoughts or attempts.
Second, we used Mendelian randomisation to explore the rela-
tionship between smoking and suicide attempts and ideation,
using genetic variants as instruments to reduce bias from
residual confounding and reverse causation.
Results
Our observational analysis showed a relationship between
smoking behaviour, suicidal ideation and attempts, particularly
between smoking initiation and suicide attempts (odds ratio,
2.07; 95% CI 1.91–2.26; P < 0.001). The Mendelian randomisation
analysis and single-nucleotide polymorphism analysis, however,
did not support this (odds ratio for lifetime smoking on suicidal
ideation, 0.050; 95% CI −0.027 to 0.127; odds ratio on suicide
attempts, 0.053; 95% CI, −0.003 to 0.110). Despite past literature
showing a positive dose-response relationship, our results
showed no clear evidence for a causal effect of smoking on
suicidal ideation or attempts.
Conclusions
This was the first Mendelian randomisation study to explore the
effect of smoking on suicidal ideation and attempts. Our results
suggest that, despite observed associations, there is no clear
evidence for a causal effect.
Keywords
Suicide; smoking; epidemiology; tobacco; Mendelian
randomisation.
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There are more than 800 000 deaths from suicide each year,1 and for
each death, there are 10–40 unsuccessful attempts.2 The World
Health Organization has recognised this significant public health
problem and the need for comprehensive suicide prevention strategies;
however, at present, there is limited evidence of sustained reductions in
suicides rates.1 Observational studies, including case-control, cohort
and cross-sectional designs, using population data3–13 and clinical
samples,14 have demonstrated a strong association between current
cigarette smoking and suicide-related behaviours characterised as idea-
tion, plans, attempts and suicide-related death. The association
remains in three meta-analyses of observational studies.15–17 These
associations have been shown to have positive dose-response relation-
ships7,11,18 that remain after adjustment for potential confounding
variables such as psychiatric symptoms,5 familial risk factors,12 socio-
economic characteristics6 and alcohol consumption.19 Smoking inter-
ventions such as imposing cigarette taxes and smoke-free air policies
are reported to be protective against suicide-related outcomes.8
Possible causal pathways
A number of psychopathological and physiological hypotheses have
been explored to determine whether this association is causal.
A number of possible biological pathways have been explored,7
including evidence that smoking lowers the levels of serotonin14
and monoamine oxidase A.20 Reduced levels of these neurotrans-
mitters are related to depressive episodes and low levels of serotonin
are also linked to increased impulsivity.14 Nicotine has been found
to act as a potent activator of the hypothalamic-pituitary-adrenal
axis and this has been linked to suicidal behaviour.21 There is
evidence to suggest that chronic cigarette smoking has long-term
neurocognitive effects, which lead to increased impulsivity and dif-
ficulties with decision-making owing to impairments in cognitive
flexibility.7,17 Alternatively, smoking causes physical health pro-
blems, including pain, sleep difficulties, chronic obstructive
pulmonary disorder, cardiovascular disease and cancer, which in
turn could lead to suicide-related behaviours.18
However, even after controlling for specific confounding vari-
ables, residual confounding could still be biasing estimates;6 for
example, as a result of social deprivation, lower levels of education
and higher levels of impulsivity.18,22 A negative control analysis
demonstrated that smoking behaviour predicted the risk of being
murdered to the same extent as the risk of suicide, which supports
the notion of residual confounding.6 Another hypothesis is of
reverse causation, namely that individuals with suicidal thoughts
may be more likely to smoke, and in addition their suicidality
could lead to reduced motivation for smoking cessation. There are
several possible explanations for reverse causation, with the most
common hypothesis being that individuals use nicotine to self-
medicate.22 Alternatively, individuals withmental illness might mis-
attribute the relief of nicotine withdrawal as relieving psychological
stress, and therefore continue to smoke.23
Applying causal inference techniques
A clear understanding of the relationship between smoking and
suicide remains to be established. A recent study demonstrated a
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causal link between smoking and risk of depression, using a
Mendelian randomisation approach.24 Mendelian randomisation
can be implemented as a type of instrumental variable analysis in
which genetic variants known to be associated with the exposure
(smoking) are used as an instrument to test for an effect on the
outcome (suicidal ideation and suicide attempts). In this study,
we apply Mendelian randomisation techniques, using genetic var-
iants identified in genome-wide association studies (GWAS), to
the relationship between smoking and suicide attempts and idea-
tion. Previous observational research in this area could be biased
by residual confounding and reverse causation, and Mendelian ran-
domisation is one way to reduce bias from these sources.25 In our
analysis, we looked at smoking initiation, smoking heaviness and
lifetime smoking, using a genetic instrument that takes into




The UK Biobank is a research resource of health data collected on
over 500 000 individuals from study centres located across the
UK. Recruitment occurred between 2006 and 2010. Participants
were aged from 39 to 70 years at recruitment (mean 56.91 years,
s.d. 7.99 years) and 54% of the sample were female. Overall, 30%
of the sample had ever smoked (8% current smokers and 22%
former smokers). Further information is available elsewhere
(https://www.ukbiobank.ac.uk/).
Measure of suicidal ideation
In the UK Biobank, participants were asked as part of a question-
naire on depressive symptoms ‘Over the last 2 weeks, how often
have you been bothered by any of the following problems?
Thoughts that you would be better off dead or of hurting yourself
in some way’ (field 20513). Participants could respond depending
on frequency of thoughts either ‘not at all’, ‘several days’, ‘more
than half the days’ or ‘nearly every day’. We recoded these into a
binary variable in which those who responded ‘not at all’ were
coded as 0 and everyone else was coded as 1. Individuals who
responded ‘prefer not to answer’ were coded as missing.
Measure of attempted suicide
In the UK Biobank, participants were first asked ‘Have you deliber-
ately harmed yourself, whether or not you meant to end your life?’
(field 20480). If they responded yes, then they were asked ‘Have you
harmed yourself with the intention to end your life?’ (field 20483).
We used both of these measures to derive one binary measure of
suicide attempt in which participants were given a score of 0 if
they responded negatively to either question, and a score of 1 if
they responded affirmatively to both questions. Individuals who
responded ‘prefer not to answer’ were coded as missing.
Measure of smoking behaviours
Participants in the UK Biobank self-reported their smoking status
(field 20116). All ever smokers were asked to report their average
number of cigarettes per day (fields 3456 and 2887). Participants
who responded ‘do not know’ or ‘prefer not to answer’ were
coded as missing.
Statistical analysis
After restricting to individuals of European ancestry with genetic
data available (to make this analysis comparable with subsequent
analyses), 337 053 individuals remained. We looked at the effect
of four smoking behaviours on suicidal ideation and attempts.
These were smoking status (ever versus never), smoking status
(current versus former within ever smokers), cigarettes per day
(within ever smokers) and lifetime smoking score. The latter is a
combination of smoking duration, smoking cessation and
smoking heaviness described in detail elsewhere.24 The effect of
each of these smoking behaviours on suicidal ideation and attempts
was estimated by logistic regression, controlling for age, gender
and socioeconomic position. All analyses were conducted with R
software, version 3.5.1, for Mac OS X (https://cran.r-project.org/
bin/macosx/).26
Mendelian randomisation analysis with summary-level
data
Smoking instrument
This Mendelian randomisation approach requires GWAS publicly
released summary data from two independent samples. The GWAS
of suicide attempt was conducted in the UK Biobank, therefore we
were unable to use the lifetime smoking instrument because it was
also constructed with the UK Biobank.24 Instead, we used the
smoking initiation (ever versus never) GWAS conducted by the
GWAS and Sequencing Consortium of Alcohol and Nicotine use
(GSCAN), taking beta values from the GWAS with UK Biobank
removed.27 Because of data-sharing restrictions, 23andMe were
also removed from the summary data used. GSCAN identified 378
conditionally independent, genome-wide significant single nucleo-
tide polymorphisms (SNPs) associated with smoking initiation,
explaining 4% of the phenotypic variance.27
Suicide attempt GWAS
The GWAS of suicide attempts was conducted in the UK Biobank,
using the question and method outlined above, with 337 199 parti-
cipants of which 2433 were cases.28 The authors did not identify
any genome-wide significant SNPs, but the summary statistics can
be used as an outcome sample in summary-level Mendelian
randomisation.
Statistical analysis
All analysis was conducted using the TwoSampleMR package29 in
R version 3.5.1, for Mac OS X (https://cran.r-project.org/bin/
macosx/).26 We used five different Mendelian randomisation
methods: inverse-variance weighted, Mendelian randomisation
(MR) Egger,30 weighted median,31 weighted mode32 and MR robust
adjusted profile score (RAPS) (MR RAPS).33 Eachmethodmakes dif-
ferent assumptions and therefore a consistent effect across multiple
methods strengthens causal evidence.34 If an SNP was unavailable
in the outcome GWAS summary statistics, then proxy SNPs were
searched for with a minimum linkage disequilibrium r2 = 0.8 and
palindromic SNPs were aligned if minor allele frequency <0.3. We
also performed Rucker’s Q-test of heterogeneity and the MR Egger
intercept test to estimate potential directional pleiotropy.30 Finally,
we performed Steiger filtering, which can indicate possible reverse
causation.35
Mendelian randomisation analysis with individual-level
data
Genotyping
UK Biobank participants provided blood samples at their initial
assessment centre. Genotyping was performed with the Affymetrix
UK BiLEVE Axiom array for 49 979 participants and the
Affymetrix UK Biobank Axiom array for 438 398 participants. The
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two arrays share 95% coverage, but chip is adjusted for in all analyses
because the UK BiLEVE sample is overrepresented for smokers.
Imputation and initial quality control steps were performed by
the Wellcome Trust Centre for Human Genetics, resulting in over
90 million variants.36
Individuals were excluded if there were gender mismatches
between reported and chromosomal gender or aneuploidy (N =
814). Medical Research Council Integrative Epidemiology Unit fil-
tering restricted the sample to individuals of European ancestry
based on the first four principal components of population struc-
ture.37 After excluding individuals who had withdrawn consent,
463 033 participants remained.37 We restricted our analysis to auto-
somes only, and used stringent filtering thresholds for SNPs of
minor allele frequency <0.01 and info >0.8.
Conducting the GWAS
Participants from the UK Biobank were randomly allocated to one
of two split halves of the genetic data. We then generated lifetime
smoking scores in sample one of these two samples, and ran a
GWAS with the UK Biobank pipeline,38 following the exact
method as described elsewhere.24
Genetic instrument
From the GWAS, genome-wide significant variants (P < 5 × 10−8)
were clumped for independence at 10 000 kb and r2 < 0.001.
Instrument validation
We tested the validity of this instrument by creating a polygenic
score from these variants in the second sample from the UK
Biobank. This was done with Plink version 1.9, in Linux (https://
www.cog-genomics.org/plink/1.9/), and by weighting each allele
by the effect size identified in the GWAS of sample one.39 This
therefore provides an independent replication sample to check
how much of the variance is explained in lifetime smoking. If this
significantly predicts lifetime smoking in the independent second
sample, then this can be used as an instrument in the individual-
level Mendelian randomisation analysis.
Statistical analysis
We conducted individual-level Mendelian randomisation with
instrumental variable regressions run in R version 3.5.1, for Mac
OS X (https://cran.r-project.org/bin/macosx/),26 with the ivreg
command from the AER package. The instrument was the polygenic
score from the GWAS in sample one. We controlled for age, gender
and ten principal components of population structure in all analyses
apart fromwhen we ran the analysis separately in males and females
(removing gender as a covariate).
Single SNP analysis
Statistical analysis
Best guess genotypes at the SNP rs1051730 were extracted with
Plink version 1.9, in Linux (https://www.cog-genomics.org/plink/
1.9/),39 in the UK Biobank full sample described above. This SNP
in the gene cluster CHRNA5-A3-B4 is known to be strongly asso-
ciated with heaviness of smoking.40–43 The variant affects the struc-
ture of neuronal nicotinic acetylcholine receptors (nAChR) such
that nicotine is less able to bind. Individuals with risk alleles that
produce nAChR deficiency are able to withstand higher nicotine
levels because they are less sensitive to its aversive effects.44 As a
result, individuals smoke on average one more cigarette per day
per risk allele.43 We used logistic regression to test whether the
number of effect alleles (A) of this SNP were associated with risk
of suicidal ideation and suicide attempts, again using the measures
described above. We controlled for age and gender in all analyses.
The logistic regressions were run in each category of smoking
status separately (ever, current, former and never smokers).
A causal effect of smoking on suicidal ideation or attempts would
be characterised by an effect of rs1051730 in all categories of




Wewanted to ensure that any effects of smoking on suicide attempts
were not the result of confounding from personality factors (e.g.
impulsivity and risk-taking) rather than direct effects of smoking.
Unfortunately, multivariable Mendelian randomisation was not
possible because of sample overlap in our risk-taking and suicide
attempt GWAS, which both used the UK Biobank. Therefore, we
conducted a follow-up analysis, using bi-directional Mendelian ran-
domisation of smoking initiation on risk-taking behaviour, with
summary-level data. As the instrument for smoking initiation, we
used the 378 SNPs from the GSCAN consortium GWAS and
effect sizes with UK Biobank removed.27 For risk-taking behaviour,
we used the Social Science Genetic Association Consortium GWAS
meta-analysed across multiple cohorts of European ancestry,45
which identified 124 SNPs associated with risk tolerance. These ana-
lyses followed the method described above for summary-level data.
Ethical approval
UK Biobank has received ethics approval from the UK National
Health Service’s National Research Ethics Service (reference 11/
NW/0382) and this work is part of approved project 9142.
Results
Observational analysis
Of the 109 649 individuals who had responded to the question of
suicidal ideation, 4515 (4%) had had suicidal thoughts. Of the 110
035 individuals who had responded to the questions of suicide
attempts and self-harm, 2405 (2%) had ever attempted suicide.
Using logistic regression, every smoking behaviour increased odds
of suicidal attempts and ideation, with the greatest effect being of
initiating smoking on odds of attempting suicide (Table 1).
Mendelian randomisation analysis with summary-level
data
Of the 378 conditionally independent SNPs associated with smoking
initiation identified by the GSCAN consortium,27 321 were available
in the GWAS summary data for suicide attempt.28 We first per-
formed the Rucker’s Q-test of heterogeneity, which did not provide
evidence for heterogeneity (Supplementary Table 1 available at
https://doi.org/10.1192/bjp.2020.68). MR Egger analysis could not
be conducted because the regression dilution I2GX was below 0.6
(I2GX unweighted ¼ 0:07). All of the other four Mendelian randomisa-
tion methods showed the same direction of effect, with smoking ini-
tiation increasing the odds of attempting suicide (Table 2). The
strongest evidence was from the inverse-variance weighted and
MR RAPS methods. The evidence was weaker for the weighted
median and weighted mode approaches, which make different
assumptions about the nature of pleiotropy. However, the
MR Egger intercept and Rucker’s Q-tests showed no clear evidence
of bias from directional pleiotropy (Supplementary Table 2).
Steiger filtering estimated that over half of the genetic instruments
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explained more variance in the outcome than the exposure, suggest-
ing that there might be reverse causation (Supplementary Table 3).
Mendelian randomisation analysis with individual-level
data
To conduct a Mendelian randomisation of lifetime smoking behav-
iour on risk of suicidal ideation and suicide attempt with individual-
level data, we first had to conduct a GWAS of suicide attempt in half
of the UK Biobank sample, using a random split. We identified 19
independent, genome-wide significant SNPs associated with life-
time smoking score. These were then extracted from the second
half of the UK Biobank sample (with no sample overlap) and
weighted by the effect size to create a polygenic score for each indi-
vidual. The second half of the UK Biobank sample is 54% female,
with mean age 56.88 years (s.d. 8.00 years). Mean lifetime
smoking score in the second half of the sample was 0.342 (s.d.
0.679). A total of 4% of individuals had experienced suicidal
thoughts (4% of females and 4% of males), and 2% of individuals
had caused themselves harm with the aim to end their life (3% of
females and 2% of males). We tested the association of lifetime
smoking score and polygenic risk score on the baseline confounders
of gender, age, socioeconomic position, alcohol consumption and
educational attainment (Supplementary Table 4). For all confoun-
ders, the association was attenuated for the polygenic risk score
compared with the observed association.
We validated that the score predicts smoking behaviour by con-
ducting a linear regression of polygenic score on lifetime smoking
behaviour in the second half of the UK Biobank. It explained
0.171% (P < 0.001) of the variance in lifetime smoking behaviour.
Finally, we conducted the individual-level Mendelian randomisa-
tion analysis of lifetime smoking polygenic risk score on suicidal
ideation and suicide attempt, controlling for age, gender and ten
principal components of population structure (Table 3). There
was no clear evidence for an effect of lifetime smoking on suicidal
ideation or suicide attempt, but a trend toward increased risk in
both analyses (Table 3).
Single SNP analysis
Finally, we extracted values for the SNP rs1051730 (A/G) from indi-
viduals in the UK Biobank. We first confirmed that an increased
number of effect alleles (A) were associated with increased
smoking behaviour (Supplementary Table 5), where we observed
the anticipated increase of approximately one cigarette more per
day per allele within ever smokers. We also showed that genotype
at rs1051730 is not associated with smoking status or the baseline
confounders of gender or alcohol consumption (Supplementary
Table 5). However, there was some evidence to suggest that geno-
type at rs1051730 was associated with educational attainment and
age (Supplementary Table 5). There was no clear evidence for an
effect of rs1051730 genotype on suicide attempts or ideation con-
trolling for age and gender (Fig. 1). There was weak evidence to
suggest that the number of rs1051730 effect alleles might reduce
risk of suicide attempts, with no effect in the never smokers and a
small protective effect in the ever smokers (Fig. 1). If smoking is
increasing risk of suicidal behaviour, we would still expect to see
no association in never smokers and the opposite effect within
ever smokers.
Smoking and impulsivity sensitivity analysis
We only saw evidence for smoking as a risk factor for suicide
attempts when the instrument was smoking initiation. One trait
associated with both smoking initiation and suicide attempts is
impulsivity. Therefore, we conducted a bi-directional Mendelian
randomisation of smoking initiation and risk-taking, using
summary-level data, which have previously been shown to be gen-
etically correlated.45 There was strong evidence of a bi-directional
causal relationship between smoking initiation and risk-taking
behaviour, suggesting that the smoking initiation SNPs might be
capturing an underlying impulsivity phenotype (Supplementary
Table 6), which could explain why we only observed effects of
smoking initiation on suicidal ideation and attempts and not for
the other smoking phenotypes. Rucker’s Q-tests showed some
evidence of heterogeneity (Supplementary Table 1) and the
MR Egger intercept showed weak evidence of bias by directional
pleiotropy (Supplementary Table 2).
Table 1. The observed association of smoking behaviour on suicidal ideation and suicide attempts controlling for age, gender and socioeconomic
position
Suicidal ideation (yes/no) Suicide attempt (yes/no)
Smoking N Odds ratio (95% CI) P-value N Odds ratio (95% CI) P-value
Ever versus never 109 301 1.39 (1.31–1.48) <0.001 109 688 2.07 (1.91–2.26) <0.001
Current versus former 45 825 1.54 (1.39–1.70) <0.001 46 011 1.54 (1.36–1.75) <0.001
Cigarettes per day 29 230 1.02 (1.01–1.02) <0.001 29 342 1.02 (1.02–1.03) <0.001
Lifetime smoking 109 301 1.42 (1.36–1.48) <0.001 109 688 1.80 (1.71–1.89) <0.001
Table 2. Mendelian randomisation analyses using summary-level data
of smoking initiation on risk of suicide attempt
Method SNPs Odds ratio (95% CI) P-value
Inverse-variance weighted 321 2.42 (1.53–3.83) <0.001
Weighted median 321 1.73 (0.85–3.50) 0.13
Weighted mode 321 1.93 (0.24–15.28) 0.53
Mendelian randomisation RAPS 321 2.86 (1.64–4.98) <0.001
SNP, single nucleotide polymorphism; RAPS, robust adjusted profile score.
Table 3. Mendelian randomisation analysis of lifetime smoking on suicidal ideation and attempt using individual-level data
Suicidal ideation Suicide attempt
N Beta (95% CI) P-value N Beta (95% CI) P-value
All 54 289 0.050 (−0.027 to 0.127) 0.21 54 500 0.053 (−0.003 to 0.110) 0.06
Females 30 480 0.069 (−0.047 to 0.185) 0.24 30 590 0.046 (−0.047 to 0.140) 0.33




The relationship between smoking and suicide-related behaviour
is not clearly understood and has important clinical implications.1,2
In this study, our observational analysis replicated previous
observed associations between smoking behaviour and suicidal
ideation and attempts, particularly between smoking initiation
and suicide attempts. We went on to explore this association with
a Mendelian randomisation approach to provide evidence about
whether or not the association is causal. Overall, theMendelian ran-
domisation analyses, including the single SNP analysis, did not
support a causal interpretation. Therefore, despite past literature
showing a positive dose-response relationship, our results do not
support a causal effect of smoking on suicide attempts or ideation.
Our findings support those of a negative control analysis demon-
strating that smoking behaviour predicted murder as strongly as it
did suicide.6
Our Mendelian randomisation results show evidence of a rela-
tionship between smoking initiation and suicidal ideation, but little
evidence of an effect of lifetime smoking on suicidal ideation. Taken
together with weak evidence for a protective effect in the single SNP
analysis, these triangulated results overall suggest that there is no
clear evidence for an effect of smoking on increased risk of suicidal
ideation or attempts.
The potential role of impulsivity
The only evidence for smoking as a risk factor was when smoking
initiation was the genetic instrument. However, our follow-up ana-
lyses suggest this could be owing to the instrument capturing under-
lying impulsivity. Smoking initiation is a complicated instrument
with both behavioural and biological components. This behavioural
component is likely to be related to impulsivity in part. This is sup-
ported by high genetic correlations between the two phenotypes.45
As there is a known correlation between impulsivity and suicidal
behaviours, we were mindful of this association. Therefore, to
examine the effect of impulsivity on our results, we undertook a
bi-directional Mendelian randomisation of smoking initiation and
risk-taking. We showed strong evidence of a bi-directional causal
relationship between smoking initiation and risk-taking behaviour,
suggesting that our results might be capturing impulsivity and not
smoking. This is further supported by the fact that when we used
other instruments of smoking behaviour (e.g. lifetime smoking
and smoking heaviness), we did not see any evidence for an effect,
and Steiger filtering suggested that many of the SNPs for smoking
initiation were not valid.
Self-harm is the result of complex interactions of personality
factors, including impulsivity, social factors and mental state.46 It
is well established that impulsivity is an important risk factor for
suicide attempts.47 It has been shown that impulsivity increases
with exposure to nicotine, returns to a normal levels with abstinence
and increases with re-challenge after abstinence.48,49 The associ-
ation with suicide attempts is not found in former smokers, and
this therefore supports the link between smoking and impulsiv-
ity.7,11,15,50 This interaction between impulsivity, smoking initiation
and suicide attempts is complex and further research is required.
For example, portioning the biological (response to nicotine) and
the behavioural (personality factors and risk-taking) components
of the smoking initiation instrument will aid future interpretation
of Mendelian randomisation analyses using smoking initiation
instruments.
Recent theoretical models of suicide (i.e. integratedmotivational
volitional model51) all fit with the ‘ideation to action’ framework,
which posits that the development of suicidal ideation and progres-
sion from ideation to attempts are distinct processes with separate
risk factors and explanations.52 Clearly, this has important implica-
tions in clinical practice and risk management. Few studies have
examined smoking within an ‘ideation to action’ framework.
A cross-sectional study found suicide attempters were more likely
than ideators to be current smokers.53 However, in the National
Comorbidity Survey, early-onset nicotine dependence was pro-
spectively associated with suicide plans, but not attempts, among
those with ideation.10 Our single SNP analysis would support the
idea of suicidal ideation and attempts being separate processes, dif-
ferentially affected by smoking heaviness, and this differentiation is
an important area that requires further research.
Strengths and limitations
This study has many strengths, as to our knowledge, it is the first to
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Fig. 1 Logistic regression results of genotype at rs1051730 on odds of suicidal ideation and suicide attempt by smoking status.
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association between smoking and suicide attempts and ideation.We
triangulated across multiple methods, multiple smoking behaviours
and multiple suicidal behaviours to improve causal inference.
However, the power of these analyses was limited by sample size.
For example, we used a split half in the Mendelian randomisation
of lifetime smoking, reducing power, which could explain why we
saw no clear evidence for an effect. Furthermore, the single SNP
analysis, designed to test the effect of smoking heaviness on suicidal
ideation and attempts, included small numbers of those experien-
cing suicidal thoughts and suicide attempts, and was therefore
underpowered. However, if anything, the trend of association was
in the opposite direction to what was hypothesised. It should also
be noted that the sample includes only non-fatal suicide attempts,
and therefore our definition of suicide attempts is narrow and the
results do not necessarily generalise to those who completed
suicide. We were also limited by the UK Biobank questions asked
for suicidal ideation and attempt. Suicide attempt questions refer
to lifetime attempts but suicidal ideation questions refer to symp-
toms. Another possible limitation is bias from reverse causation.
As attempts were unsuccessful, a pathway from attempts to
smoking initiation is possible. Furthermore, Steiger filtering esti-
mated that over half of the smoking initiation genetic instruments
explained more variance in suicide attempts than smoking initi-
ation. As discussed, this could be because of the instruments captur-
ing underlying impulsivity and risk-taking.
In conclusion, this was the first Mendelian randomisation study
to explore the effect of smoking on suicidal ideation and attempts.
Our results suggest that, despite observed associations, when we tri-
angulated across multiple Mendelian randomisation methods, there
was no clear evidence for a causal effect of smoking behaviour. This
supports recent evidence suggesting that suicidal ideation and
suicide attempts are different processes. Furthermore, this work
has highlighted the complexity of unpicking the behavioural from
the biological components of smoking behaviours.
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